Because the body already recognizes this molecule, supplementation is generally safe when taken appropriately
Currently, research on GLP-1 agonists during pregnancy is limited, and most guidelines recommend against their use while pregnant due to potential unknown effects on fetal development
D Metformin in T1D: modest insulin-dose reduction, commonly cited around 5% in practice summaries
Analysis of subpopulations by velocity sedimentation and multiple markers
BPC-157 is soluble in DMSO at concentrations up to approximately 5 mg/mL, and DMSO is typically selected when preparing concentrated stock solutions for cell culture assays where final DMSO concentration in the well can be kept below 0.1% to avoid cytotoxicity artifacts
History: In the early 2000s, GLP-1-based drugs (exenatide and liraglutide) were developed for the treatment of type 2 diabetes